Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000537863 | SCV000636929 | benign | Dilated cardiomyopathy 1AA; Primary familial hypertrophic cardiomyopathy | 2024-12-11 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001700404 | SCV002073973 | uncertain significance | not provided | 2022-01-25 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Reported in ClinVar as a variant of uncertain significance (ClinVar Variant ID# 463190) |
Ambry Genetics | RCV002350237 | SCV002646034 | uncertain significance | Cardiovascular phenotype | 2024-07-02 | criteria provided, single submitter | clinical testing | The p.R398C variant (also known as c.1192C>T), located in coding exon 11 of the ACTN2 gene, results from a C to T substitution at nucleotide position 1192. The arginine at codon 398 is replaced by cysteine, an amino acid with highly dissimilar properties. This variant was detected in a cardiomyopathy genetic testing cohort as well as a dilated cardiomyopathy cohort; however, clinical details were limited, and additional cardiac variants were detected in some cases. (van Lint FHM et al, 2019 Jun;27:304-309; Horvat C et al. Genet. Med., 2019 01;21:133-143). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Diagnostic Laboratory, |
RCV000604601 | SCV000733999 | uncertain significance | Dilated cardiomyopathy 1AA | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV001700404 | SCV001924505 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001700404 | SCV001931804 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001700404 | SCV001956140 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001700404 | SCV001973377 | uncertain significance | not provided | no assertion criteria provided | clinical testing |